Literature DB >> 15637468

Residual urinary concentrating ability and AQP2 expression in a rat model for chronic renal failure.

Katsuya Suzuki1, Ryo Hatano, Mari Michimata, Itsuro Kazama, Michiko Suzuki, Noriyuki Miyama, Akira Sato, Susumu Satomi, Yutaka Ejima, Teruyuki Yanagisawa, Mitsunobu Matsubara.   

Abstract

BACKGROUND: In chronic renal failure (CRF), a defect in urinary concentrating ability develops gradually as the renal failure progresses. Although several molecular mechanisms associated with renal urinary concentration are reported to be impaired in a rat model for renal failure, the mechanisms underlying residual urinary concentration ability in CRF remain to be elucidated.
METHODS: Rats that underwent an 8-week recovery period after 5/6 nephrectomy were used as the model for CRF. Urinary concentration was induced by 24-hour water restriction. Plasma osmolality and arginine vasopressin (AVP) were measured from blood sampled by inserting a catheter into the femoral artery before and after the water restriction. AQP2 mRNA expression in the inner medulla was examined by competitive PCR and in situ hybridization, and protein expression, by Western blotting. Rats that underwent sham operation were used as control.
RESULTS: Water restriction significantly reduced urine volume and increased urine osmolality in CRF rats, although such changes were much less than those in sham-operated rats. Plasma AVP was elevated at the basal condition, and further elevation was noted after water restriction. AQP2 mRNA signals were significantly intensified by water restriction even in CRF rats, although the increase was limited as in the case of urine osmolality. Western blotting also showed a small but significant enhancement of protein signals in response to water restriction in CRF rats.
CONCLUSIONS: We noted a weak but significant response of AQP2 expression to dehydration in CRF rats. This response in the collecting duct may be one of the factors contributing to residual urinary concentrating ability in CRF. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637468     DOI: 10.1159/000081798

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN: 1660-2137


  8 in total

Review 1.  Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease.

Authors:  Itsuro Kazama
Journal:  J Physiol Sci       Date:  2014-08-06       Impact factor: 2.781

2.  Osmoregulatory defect in adult mice associated with deficient prenatal expression of six2.

Authors:  S Jack Somponpun; Brittany Wong; Thomas E Hynd; Benjamin Fogelgren; Scott Lozanoff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-08       Impact factor: 3.619

3.  Compensatory thrombopoietin production from the liver and bone marrow stimulates thrombopoiesis of living rat megakaryocytes in chronic renal failure.

Authors:  Itsuro Kazama; Yasuhiro Endo; Hiroaki Toyama; Yutaka Ejima; Shin Kurosawa; Yoshimichi Murata; Mitsunobu Matsubara; Yoshio Maruyama
Journal:  Nephron Extra       Date:  2011-10-22

4.  Overexpression of Delayed Rectifier K(+) Channels Promotes In situ Proliferation of Leukocytes in Rat Kidneys with Advanced Chronic Renal Failure.

Authors:  Itsuro Kazama; Yoshio Maruyama; Yasuhiro Endo; Hiroaki Toyama; Yutaka Ejima; Mitsunobu Matsubara; Shin Kurosawa
Journal:  Int J Nephrol       Date:  2012-05-31

Review 5.  Roles of lymphocyte kv1.3-channels in the pathogenesis of renal diseases and novel therapeutic implications of targeting the channels.

Authors:  Itsuro Kazama
Journal:  Mediators Inflamm       Date:  2015-03-18       Impact factor: 4.711

Review 6.  Dysnatremias in Chronic Kidney Disease: Pathophysiology, Manifestations, and Treatment.

Authors:  Soraya Arzhan; Susie Q Lew; Todd S Ing; Antonios H Tzamaloukas; Mark L Unruh
Journal:  Front Med (Lausanne)       Date:  2021-12-06

Review 7.  Management of severe hyponatremia: infusion of hypertonic saline and desmopressin or infusion of vasopressin inhibitors?

Authors:  Antonios H Tzamaloukas; Joseph I Shapiro; Dominic S Raj; Glen H Murata; Robert H Glew; Deepak Malhotra
Journal:  Am J Med Sci       Date:  2014-11       Impact factor: 2.378

8.  Effect of Chronic Kidney Disease on Changes in Vasopressin System Expression in the Kidney Cortex in Rats with Nephrectomy.

Authors:  Katarzyna Czarzasta; Agnieszka Cudnoch-Jedrzejewska; Longin Niemczyk; Robert Wrzesien; Marzanna Tkaczyk; Liana Puchalska; Marek Saracyn; Wawrzyniec Zmudzki; Stanisław Niemczyk
Journal:  Biomed Res Int       Date:  2018-06-14       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.